Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2019-06-24 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Interim / Quarterly Report Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended 31st March 2019, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial data on remuneration, purchases, contributions, donations, and payables related to key management personnel and related parties. The document is comprehensive and includes actual financial figures for the half-year period, indicating it is a substantive financial disclosure rather than a mere announcement or certification. Such disclosures are typically part of interim or quarterly financial reporting. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2019-06-24 English
Please find enclosed disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 31st March, 2019. ....
Regulatory Filings
2019-06-21 English
Resignation
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 177 characters, which is extremely short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2019-06-21 English
We hereby notify that Mr. Peter Lankau, Independent Director of the Company has submitted his resignation effective 1st July, 2019 due to his other professional engagements which he is ....
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for omitted pictures and no substantive text or financial data. The true document length is only 177 characters, indicating it is extremely short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings without substantive information.
2019-06-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notice published in newspapers regarding the transfer of shares to the Investor Education and Protection Fund (IEPF) due to unclaimed dividends for seven consecutive years or more. It references the Companies Act, 2013 and related rules, and provides instructions to shareholders about claiming dividends before shares are transferred. The document is an announcement informing shareholders about a corporate action related to unclaimed dividends and share transfers, not a financial report or detailed filing. It is not an annual report, interim report, earnings release, or any detailed financial or management report. It is also not a proxy solicitation, voting result, or board change announcement. The document is a regulatory announcement to shareholders about compliance with statutory requirements and corporate action. Given its nature and length (7326 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-06-17 English
Please find attached herewith copies of newspaper notice published in Business Standard (English) and Sakal (Marathi) on 15th June, 2019. The above notice is for shareholders who ....
Regulatory Filings
2019-06-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.